Paul Tudor Jones Haemonetics Corp Transaction History
Tudor Investment Corp Et Al
- $26.8 Billion
- Q3 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Haemonetics Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 3,065 shares of HAE stock, worth $209,308. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,065Holding current value
$209,308% of portfolio
0.0%Shares
13 transactions
Others Institutions Holding HAE
# of Institutions
333Shares Held
53.8MCall Options Held
689KPut Options Held
345K-
Black Rock Inc. New York, NY5.96MShares$407 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$353 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.44MShares$303 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA4.2MShares$287 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY4.03MShares$275 Million0.26% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.5B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...